Tenants

5M Biomed, LLC

Founded by a group of scientists specializing in life sciences, biomaterial engineering and medical imaging, 5M Biomed, LLC, is developing advanced biomedical technology to enable precision medicine. Using innovative technology, 5M Biomed provides solutions and technologies for in vitro diagnosis, precision and quantitative imaging, and therapeutic agent delivery platforms through novel bio-inspired magnetic nano-materials and molecularly targeted imaging methods.

Andson Biotech Inc. 

Andson Biotech has developed a suite of next generation biosensor and bio analytics technologies that improve the speed, cost and success rate of bringing Advanced Therapeutics to patients. Our flagship microfluidic-based platform, the DynaChip, couples with workhorse biopharma analytical/QC tools known as mass spectrometers to enable simple and accurate analytics in just minutes instead of the standard hours-to-days.

We are developing our technology alongside a broad spectrum of biopharma stakeholders including leading cell-and-gene therapy companies, world-class CDMOs and even physician scientists developing new types of cell-therapies. We are working with these early adopters to develop our platform for three initial applications:

1) To accelerate and simplify “common” analytical measurements carried out by mass spectrometrists all over the world

2) To develop better, faster assays to accelerate the drug discovery process and get advanced therapies to market faster

3) To provide predictive process control for reduced in-process failures of complex and costly biopharma processes

Chembind, LLC

Chembind, LLC, is a pharmaceutical company dedicated to promoting the research and development of sugar chemistry, glycobiology and medicine. The company also works to invent and design new isotope labeled compounds, antibody-drug conjugates and in vitro diagnosis reagents.

CureMast, Inc.

CureMast, Inc. is a start-up venture having the objective of providing dairy farmers and veterinarians with an improved means of curing mastitis infections and enabling a faster return of infected cows back to the commercial milk-producing herd. There proprietary intramammary infusion product represents a departure from the current use of antibiotics and is specifically formulated to two to three times each day.

DeoBioSciences

DeoBioSciences is a preclinical/early stage, biotech C-corp. developing an experimental drug candidate for a range of advanced/metastatic carcinoma types in people and, possibly, their domestic pets. The drug candidate is based on a naturally sourced, selectively cytotoxic compound, identified through bioprospecting leads. Its potential for clinical efficacy is being evaluated via functional assays in statistically reliable PDX translational models.

NanoResearch, Inc.

NanoResearch, Inc., works to invent and design new manufacturing enterprise and/or license new nanomaterials, energy storage materials, energy storage devices and smart mechanical products.

Palate Therapeutics

Palate Therapeutics pioneers metabolic disease prevention by curbing sugar intake. Their innovation, an oral gene therapy using oligonucleotides, modifies taste buds to reduce sugar cravings. This approach holds potential to combat obesity and its health implications effectively.

Piezo Therapeutics

Piezo Therapeutics aims to transform the delivery of nucleic acid medicines to enable improved safety, affordability, and scalability. Piezo is developing a uniquely engineered platform that uses electric pulses and microneedles to deliver a broad range of therapeutics inside the body. Its piezoelectric technology offers improved safety and efficacy and is simple, cost-effective, and rapid to produce at scale. Founded by experts in the field of drug delivery and commercial translation, Piezo’s diverse team aims to help translate the next generation of nucleic acid medicines. For more information, please email [email protected].

Learn more: https://www.prweb.com/releases/2023/01/prweb19121712.htm

ProgenaCare Global, LLC

ProgenaCare is a regenerative healthcare company dedicated to improving wound care healing, leveraging proprietary medical device technologies and biotechnology research and development.